Effects of post-inhalation treatment with interleukin-12 on airway hyper-reactivity, eosinophilia and interleukin-18 receptor expression in a mouse model of asthma

Clinical and Experimental Allergy

Volumn 32, Issue 4, 2002, Pages 641-649

  Kuribayashi, K ^a   Kodama, T ^a   Okamura, H ^a   Sugita, M ^a   Matsuyama, T ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; Cytokines; Interferon ; Interleukin 12; Interleukin 18 receptor; Th1 Th2 balance

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 4; MONOCLONAL ANTIBODY; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; ATTENUATION; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG EFFECT; EXPOSURE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INHIBITION KINETICS; LOEFFLER PNEUMONIA; LUNG; LUNG PARENCHYMA; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RECEPTOR UPREGULATION; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; T LYMPHOCYTE; TH2 CELL; TISSUE LEVEL;

ADMINISTRATION, INHALATION; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; IMMUNOGLOBULIN E; INTERLEUKIN-12; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; LUNG; MALE; MICE; MICE, INBRED C57BL; OVALBUMIN; PULMONARY EOSINOPHILIA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-18;

EID: 0036224842     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0954-7894.2002.01346.x     Document Type: Article

References (40)

1. + T cells
2. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice
3. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
4. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
5. Immunomodulatory effect of IL-12 on allergic lung inflammation depends on timing of doses
6. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice
7. Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways
8. Local treatment with IL-12 is effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice
9. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-g production
10. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
11. Prevention of Th2-1ike cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresonsiveness, eosinophilia, and serum IgE levels
12. IL-18 deficiency selectively enhances allergen-induced eosinophilia in mice
13. IL-18 up-regulates perforin-mediated NK activity without perforin messenger RNA expression by binding to constitutively expressed IL-18R
14. Generation of IL-18 receptor-deficient mice: Evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor
15. + T cells
16. Kinetics of apoptosis in the lung of mice with allergic airway inflammation
17. Interleukin-13: Central mediator of allergic asthma
18. Requirement for IL-13 independently of IL-4 in experimental asthma
19. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity
20. Differential modulation of interleukin-4 and interleukin-13 secretion from human peripheral blood mononuclear cells
21. Regulation of acute lung injury by endogenous IL-13
22. Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation
23. Structural consequence of airway inflammation in asthma
24. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-γ production from activated B cells
25. Recombinant interleukin-12 suppresses the synthesis of IgE by interleukin-4 stimulated human lymphocytes
26. Interleukin-18: A novel cytokine that auguments both innate and acquired immunity
27. +T cells, IL-4 and STAT6
28. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively
29. Interleukin-18 enhances antigen-induced eosinophil recruitment into the mouse airways
30. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB
31. IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12
32. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells
33. +, and CD4-CD8T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18
34. IL-18 is a potent coinducer of IL-13 in NK and T cells: A new potential role for IL-18 in modulating the immune response
35. Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody
36. IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation
37. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
38. IFN-γ-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma
39. Inhibition of in vitro immunoglobulin production by IL-12 in murine chronic graft-vs.-host disease: Synergism with IL-18
40. A mechanism underlying synergy between IL-12 and IFN-γ-producing factor in enhanced production oflFN-γ